Nanotechnology for In vivo Targeted siRNA Delivery
Authors:
- 1 January 2014
- book chapter
- Published by Elsevier
- Vol. 88, 37-69
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus InfectionMolecular Therapy, 2013
- Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured CoreThe Journal of Physical Chemistry C, 2012
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012
- Action and Reaction: The Biological Response to siRNA and Its Delivery VehiclesMolecular Therapy, 2012
- In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modificationNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene SilencingMolecular Therapy Nucleic Acids, 2012
- Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting CellsMolecular Therapy, 2011
- Type 2 diabetes across generations: from pathophysiology to prevention and managementThe Lancet, 2011
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based MechanismsMolecular Therapy, 2010
- Development of Lipidoid–siRNA Formulations for Systemic Delivery to the LiverMolecular Therapy, 2009